NCT05153785 2026-01-15
Perioperative Intravenous Lidocaine in Liver Surgery
Lund University Hospital
Phase 2/3 Completed
Clinical Trials
15 trialsNCT05033522 2025-10-23
ALIVE
Mirror Biologics, Inc.
Phase 2/3 Suspended
NCT06478108 2024-06-27
Interventional Software for Multi-immunotherapy of Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT05322187 2022-04-11
sPLENTY-pc
RenJi Hospital
Phase 2/3 Unknown
NCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT03592706 2020-04-16
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Ivy Life Sciences, Co., Ltd
Phase 2/3 Unknown
NCT01932385 2018-02-14
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
Qingdao Central Hospital
Phase 2/3 Completed
NCT01901692 2017-09-18
START
Asan Medical Center
Phase 2/3 Completed
NCT02829359 2017-06-12
HBV-DNA(-)
Guangxi Medical University
Phase 2/3 Completed
NCT00304135 2016-05-30
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00332280 2013-03-20
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Auron Healthcare GmbH
Phase 2/3 Terminated
NCT01655641 2012-10-16
TMGS
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Phase 2/3 Unknown
NCT00034333 2005-06-24
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer
FeRx
Phase 2/3 Terminated
NCT00057382 2005-06-24
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
Tularik
Phase 2/3 Terminated